Skip to main content
. 2021 Jul 16;12:675756. doi: 10.3389/fneur.2021.675756

Table 1.

Etiologies of seizures following allo-HSCT.

Categories
Drug-related neurotoxicity
   Chemotherapy (Bu)
   Immunosuppressants (CsA, TCA)
   Other drugs (antibiotics: unsubstituted penicillin, fourth-generation cephalosporins: imipenem, fluoroquinolones: antifungal - azole, antiviral agents - foscarnet)
Metabolic disturbances
   Hyponatremia, hypomagnesemia, hypocalcemia, hypernatremia, hypoglycemia
   Blood glucose abnormalities
   End-stage organ failure (hepatic or uremic encephalopathy)
Intracranial infection
   Viruses (human herpesvirus-6, cytomegalovirus, herpes simplex virus)
   Fungi (Aspergillus, Candida)
   Bacteria (G+, G–)
Cerebrovascular events
   Hemorrhagic diseases (intraparenchymal hemorrhage, subdural hematoma, subarachnoid, hemorrhage, multiple hemorrhage lesions)
   Cerebral thrombotic events
   Transplantation-associated thrombotic microangiopathy
Others
   Post-transplantation lymphoproliferative disorders (PTLD)
   Relapse of CNS
   Secondary neoplasm (meningioma, glioblastoma, astrocytoma, etc.)
   Vasculitis or immune-mediated encephalitis caused by cGVHD
   Unknown